ZFP30
gene geneOn this page
Also known as ZNF745KIAA0961
Summary
ZFP30 (ZFP30 zinc finger protein, HGNC:29555) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 30 homolog (Q9Y2G7). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 22835 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 73 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001320669
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29555 |
| Approved symbol | ZFP30 |
| Name | ZFP30 zinc finger protein |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF745, KIAA0961 |
| Ensembl gene | ENSG00000120784 |
| Ensembl biotype | protein_coding |
| OMIM | 617317 |
| Entrez | 22835 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 18 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000351218, ENST00000477900, ENST00000514101, ENST00000586732, ENST00000587199, ENST00000587809, ENST00000588979, ENST00000589018, ENST00000589676, ENST00000589789, ENST00000591444, ENST00000684514, ENST00000858104, ENST00000858105, ENST00000858106, ENST00000858107, ENST00000858108, ENST00000858109, ENST00000937928, ENST00000937929, ENST00000937930, ENST00000943956
RefSeq mRNA: 7 — MANE Select: NM_001320669
NM_001320666, NM_001320667, NM_001320668, NM_001320669, NM_001320670, NM_001320671, NM_014898
CCDS: CCDS33005
Canonical transcript exons
ENST00000684514 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001398816 | 37654712 | 37654879 |
| ENSE00002514063 | 37643265 | 37643363 |
| ENSE00002529404 | 37644610 | 37644736 |
| ENSE00003556546 | 37647814 | 37647899 |
| ENSE00003917786 | 37655420 | 37655465 |
| ENSE00003921180 | 37631006 | 37636305 |
Expression profiles
Bgee: expression breadth ubiquitous, 218 present calls, max score 89.60.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.7732 / max 108.5483, expressed in 1584 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180723 | 4.9616 | 1551 |
| 180729 | 0.4141 | 232 |
| 180731 | 0.3882 | 168 |
| 180722 | 0.0093 | 2 |
Top tissues by expression
264 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 89.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.59 | gold quality |
| ventricular zone | UBERON:0003053 | 84.22 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.22 | gold quality |
| colonic epithelium | UBERON:0000397 | 83.17 | gold quality |
| oocyte | CL:0000023 | 82.98 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.25 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.61 | gold quality |
| secondary oocyte | CL:0000655 | 79.97 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 79.86 | gold quality |
| embryo | UBERON:0000922 | 79.68 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.05 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.81 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 78.63 | gold quality |
| left testis | UBERON:0004533 | 78.20 | gold quality |
| right testis | UBERON:0004534 | 78.11 | gold quality |
| cerebellum | UBERON:0002037 | 78.10 | gold quality |
| tendon | UBERON:0000043 | 77.84 | gold quality |
| seminal vesicle | UBERON:0000998 | 77.78 | gold quality |
| testis | UBERON:0000473 | 77.36 | gold quality |
| endometrium | UBERON:0001295 | 77.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.33 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.11 | gold quality |
| corpus callosum | UBERON:0002336 | 75.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.42 | gold quality |
| left ovary | UBERON:0002119 | 74.17 | gold quality |
| sural nerve | UBERON:0015488 | 74.07 | gold quality |
| ovary | UBERON:0000992 | 74.04 | gold quality |
| body of uterus | UBERON:0009853 | 74.01 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 359.75 |
| E-MTAB-7249 | no | 191.02 |
| E-ANND-3 | no | 5.45 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
102 targeting ZFP30, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
Literature-anchored findings (GeneRIF, showing 1)
- Using murine and human in vitro and in vivo models, study demonstrated that ZFP30 promotes adipogenesis by directly targeting and activating a retrotransposon-derived Pparg2 enhancer. Through mechanistic studies, study further show that ZFP30 recruits the co-regulator KAP1, which acts as a ZFP30 co-activator in this adipogenic context. (PMID:31000713)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp30 | ENSMUSG00000047473 |
| rattus_norvegicus | Zfp84 | ENSRNOG00000055519 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 30 homolog — Q9Y2G7 (reviewed: Q9Y2G7)
Alternative names: Zinc finger protein 745
All UniProt accessions (5): D3Y2A0, Q9Y2G7, K7EK76, K7EMM3, K7EPH5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (7): NP_001307595, NP_001307596, NP_001307597, NP_001307598, NP_001307599, NP_001307600, NP_055713 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (18 total): zinc finger region 13, cross-link 2, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y2G7-F1 | 72.41 | 0.13 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 75, 110, 141
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 107 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, EPPERT_LSC_R, WONG_ADULT_TISSUE_STEM_MODULE, E2F3_UP.V1_UP, RB_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, DYRK1A_TARGET_GENES, HMG20B_TARGET_GENES, HMGA1_TARGET_GENES, KLF7_TARGET_GENES, OVOL3_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
516 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP30 | SPDYE11 | P0DTA3 | 507 |
| ZFP30 | C12orf42 | Q96LP6 | 357 |
| ZFP30 | ZDHHC11B | P0C7U3 | 348 |
| ZFP30 | CNTNAP3B | Q96NU0 | 322 |
| ZFP30 | TCP11L2 | Q8N4U5 | 319 |
| ZFP30 | DIPK1C | Q0P6D2 | 318 |
| ZFP30 | SPATA32 | Q96LK8 | 310 |
| ZFP30 | KCTD19 | Q17RG1 | 302 |
| ZFP30 | TMC7 | Q7Z402 | 286 |
| ZFP30 | LRRC14 | Q15048 | 282 |
| ZFP30 | JKAMP | Q9P055 | 271 |
| ZFP30 | ZNF512 | Q96ME7 | 270 |
| ZFP30 | SP140L | Q9H930 | 270 |
| ZFP30 | PLSCR2 | Q9NRY7 | 269 |
| ZFP30 | JADE1 | Q6IE81 | 258 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AURKB | SEC16A | psi-mi:“MI:2364”(proximity) | 0.570 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX6 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| LYAR | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK7 | TAF4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| GOLGA2 | MYO1C | psi-mi:“MI:2364”(proximity) | 0.270 |
| MYOD1 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (14): ZFP30 (Proximity Label-MS), ZFP30 (Proximity Label-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-RNA), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-RNA)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
73 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 61 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 224819 | NM_001320669.3(ZFP30):c.730T>C (p.Cys244Arg) | Likely pathogenic |
SpliceAI
2198 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37647812:A:AC | donor_gain | 1.0000 |
| 19:37647813:C:CC | donor_gain | 1.0000 |
| 19:37647813:CA:C | donor_gain | 1.0000 |
| 19:37647813:CACGA:C | donor_gain | 1.0000 |
| 19:37647895:CAGAG:C | acceptor_gain | 1.0000 |
| 19:37647896:AGAGC:A | acceptor_loss | 1.0000 |
| 19:37647897:GAG:G | acceptor_gain | 1.0000 |
| 19:37647897:GAGC:G | acceptor_loss | 1.0000 |
| 19:37647899:GC:G | acceptor_loss | 1.0000 |
| 19:37647900:C:CC | acceptor_gain | 1.0000 |
| 19:37647901:T:C | acceptor_loss | 1.0000 |
| 19:37655109:C:A | donor_gain | 1.0000 |
| 19:37636305:TC:T | acceptor_loss | 0.9900 |
| 19:37636306:C:G | acceptor_loss | 0.9900 |
| 19:37636307:T:G | acceptor_loss | 0.9900 |
| 19:37644642:A:AC | donor_gain | 0.9900 |
| 19:37647808:ACTT:A | donor_loss | 0.9900 |
| 19:37647810:T:TA | donor_loss | 0.9900 |
| 19:37647811:TACAC:T | donor_loss | 0.9900 |
| 19:37647812:ACAC:A | donor_loss | 0.9900 |
| 19:37647813:CACG:C | donor_gain | 0.9900 |
| 19:37647896:AGAG:A | acceptor_gain | 0.9900 |
| 19:37647913:A:C | acceptor_gain | 0.9900 |
| 19:37654710:A:AC | donor_gain | 0.9900 |
| 19:37654711:C:CC | donor_gain | 0.9900 |
| 19:37655108:T:TA | donor_gain | 0.9900 |
| 19:37655230:C:CT | donor_gain | 0.9900 |
| 19:37655231:T:TT | donor_gain | 0.9900 |
| 19:37686519:CAGA:C | acceptor_gain | 0.9900 |
| 19:37686523:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000010153 (19:37644127 C>A,T), RS1000047376 (19:37638619 G>T), RS1000052870 (19:37656454 T>C,G), RS1000081452 (19:37645433 T>C), RS1000085011 (19:37656186 G>A), RS1000312596 (19:37633143 C>A,T), RS1000323916 (19:37632987 A>G), RS1000545072 (19:37639661 T>G), RS1000689267 (19:37645796 A>T), RS1000743002 (19:37646084 C>T), RS1001054056 (19:37657727 G>A), RS1001152048 (19:37655306 A>C), RS1001314146 (19:37634835 T>C,G), RS1001328966 (19:37634384 A>G), RS1001349231 (19:37649682 G>A,C)
Disease associations
OMIM: gene MIM:617317 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_55 | Refractive error | 7.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 4 |
| trichostatin A | decreases expression, affects cotreatment | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| manganese chloride | increases expression, increases abundance | 1 |
| vanadyl sulfate | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Manganese | increases expression, increases abundance | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.